Valproic acid-d15

CAT: 0804-HY-10585S2-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-10585S2-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Valproic acid-d15 is the deuterium labeled Valproic acid. Valproic acid (VPA; 2-Propylpentanoic Acid) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches[1][2].
CAS Number
[362049-65-8]
Product Name Alternative
VPA-d15; 2-Propylpentanoic acid-d15
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Endogenous Metabolite; HDAC; HIV; Mitophagy; Notch
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease; Neuronal Signaling; Stem Cell/Wnt
Field of Research
Cancer
Purity
99.80
Solubility
10 mM in DMSO|DMSO : 100mg/mL (ultrasonic)
Smiles
[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C(C(O)=O)([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]
Molecular Formula
C8HD15O2
Molecular Weight
159.30
Precautions
H302, H315, H319, H335
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Valproic acid, et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001 Sep 28;276 (39) :36734-41.|[3]Zhang ZH, et al. Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi 1 leukemia cells. Mol Med Rep. 2013 Nov 28.|[4]Platta CS, et al. Valproic acid induces Notch1 signaling in small cell lung cancer cells. J Surg Res. 2008 Jul;148 (1) :31-7.|[5]Cohen OS, et al. Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Int J Dev Neurosci. 2013 Dec;31 (8) :740-50.|[6]Han BR, et al. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis. Oncol Rep. 2013 Dec;30 (6) :2999-3005.|[7]Avery LB, et al. Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice. Mol Pharmacol. 2014 Jan;85 (1) :1-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W769286Valproic acid β-D-glucuronide-d15
HY-10585-01Valproic acid
HY-41417S-01Octanoic acid-d15
HY-133160-01Valproic acid hydroxamate
HY-10585A-01Valproic acid (sodium)
HY-10585R-01Valproic acid (Standard)
HY-10585S1-01Valproic acid-d6
HY-10585S-01Valproic acid-d4
HY-W794759Valproic acid (magnesium)
HY-W400496-01Valproic acid β-D-glucuronide

Alternative Products

CatalogName
MF-0101622-01Valproic Acid-d15
468559-01Valproic Acid-d15 β-D-Glucuronide
TRC-V094763-1MGValproic Acid-d15 Beta-D-Glucuronide
MBS3606908-01Valproic acid
QY-E05900Human Valproic Acid
sc-257944Octanoic-d15 acid

Popular Products